Pages that link to "Q45143705"
Jump to navigation
Jump to search
The following pages link to A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia (Q45143705):
Displaying 50 items.
- Oxidative stress in preeclampsia and the role of free fetal hemoglobin (Q26830141) (← links)
- A leading role for the immune system in the pathophysiology of preeclampsia (Q27003069) (← links)
- Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases (Q28483381) (← links)
- Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1 (Q28507470) (← links)
- VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model (Q30432040) (← links)
- A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. (Q30433214) (← links)
- Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport (Q30436024) (← links)
- Uterine DCs are crucial for decidua formation during embryo implantation in mice (Q30484560) (← links)
- Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo (Q30499862) (← links)
- Variability in mRNA expression of fms-like tyrosine kinase-1 variants in normal and preeclamptic placenta. (Q31154111) (← links)
- Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia (Q33349894) (← links)
- Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women. (Q33401202) (← links)
- Pre-eclampsia part 1: current understanding of its pathophysiology (Q33416340) (← links)
- Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia (Q33438425) (← links)
- Enhancement of the HIF-1α/15-LO/15-HETE axis promotes hypoxia-induced endothelial proliferation in preeclamptic pregnancy (Q33568126) (← links)
- Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy (Q33826353) (← links)
- A unifying hypothesis for scleroderma: identifying a target cell for scleroderma (Q33889221) (← links)
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. (Q33899627) (← links)
- New developments in the pathogenesis of preeclampsia (Q33935675) (← links)
- Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation. (Q34080032) (← links)
- The vascular endothelial growth factor family in adverse pregnancy outcomes. (Q34267491) (← links)
- In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy (Q34505704) (← links)
- Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice (Q34517776) (← links)
- Reduced uterine perfusion pressure induces hypertension in the pregnant mouse (Q34627421) (← links)
- First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia (Q34655258) (← links)
- Angiogenic Factors and Preeclampsia (Q34714082) (← links)
- Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia (Q34731047) (← links)
- Preeclampsia and the Anti-Angiogenic State (Q34920271) (← links)
- The biology of preeclampsia (Q35037064) (← links)
- Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta (Q35049491) (← links)
- Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease (Q35143007) (← links)
- Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. (Q35178348) (← links)
- Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice (Q35362708) (← links)
- Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia (Q35813842) (← links)
- Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia (Q35871466) (← links)
- Transcriptome landscape of the human placenta (Q36012499) (← links)
- Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. (Q36253217) (← links)
- Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration (Q36274124) (← links)
- Angiogenic factors in preeclampsia and related disorders (Q36526596) (← links)
- Ectodomain cleavage of FLT1 regulates receptor activation and function and is not required for its downstream intracellular cleavage. (Q36932603) (← links)
- Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. (Q37024446) (← links)
- A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia (Q37257615) (← links)
- Is scleroderma a vasculopathy? (Q37417756) (← links)
- Placental abnormalities and preeclampsia in trisomy 13 pregnancies (Q37433253) (← links)
- Preeclampsia: the role of angiogenic factors in its pathogenesis (Q37512886) (← links)
- Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy (Q37616832) (← links)
- Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy (Q37690917) (← links)
- Target Inhibition in Antiangiogenic Therapy A Wide Spectrum of Selectivity and Specificity (Q37816164) (← links)
- Molecular Basis for Endothelial Lumen Formation and Tubulogenesis During Vasculogenesis and Angiogenic Sprouting (Q37863911) (← links)
- Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer (Q37866785) (← links)